Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Acasti Pharma Inc.

Start price
Target price
Perf. (%)
€11.77
12.09.21
€15.00
12.09.22
-60.64%
13.09.22

Could be worthwhile Investment >10% per year
buy
AEterna Zentaris Inc.

Start price
Target price
Perf. (%)
€4.77
07.08.22
-
07.08.23
4.82%
26.08.22

buy
Emerald Health Therapeutics Inc

Start price
Target price
Perf. (%)
€0.13
08.07.21
-
08.07.22
-77.81%
08.07.22

Edesa Biotech Inc

Start price
Target price
Perf. (%)
€7.09
15.10.21
€2.00
15.10.22
-76.35%
15.06.22

Edesa Biotech Inc

Start price
Target price
Perf. (%)
€7.09
15.10.21
€3.00
15.10.22
-76.35%
15.06.22

buy
NeutriSci International Inc

Start price
Target price
Perf. (%)
€0.020
06.05.22
-
06.06.22
33.00%
07.06.22

buy
Antibe Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.48
08.07.21
-
08.07.22
-80.56%
21.05.22

buy
Scryb Inc.

Start price
Target price
Perf. (%)
€0.40
14.03.21
€1.95
14.03.22
-72.88%
15.03.22

buy
Sirona Biochem Corp.

Start price
Target price
Perf. (%)
€0.26
28.04.21
€3.00
28.04.22
-49.42%
18.01.22

Acasti Pharma Inc.

Start price
Target price
Perf. (%)
€24.00
10.01.21
-
10.01.22
-68.75%
11.01.22

buy
Acasti Pharma Inc.

Start price
Target price
Perf. (%)
€7.32
25.12.21
€12.00
25.12.22
-9.02%
08.01.22

buy
BELLUS Health Inc.

Start price
Target price
Perf. (%)
€6.74
12.12.21
-
12.12.22
4.53%
24.12.21

buy
BELLUS Health Inc.

Start price
Target price
Perf. (%)
€4.95
10.10.21
€8.00
31.12.23
58.11%
13.12.21

Could be very worthwhile Investment >20% year
buy
BELLUS Health Inc.

Start price
Target price
Perf. (%)
€4.62
02.12.21
-
02.12.22
45.82%
12.12.21

Risky Investment
buy
Nuvo Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€0.94
15.09.21
€1.20
15.09.22
11.23%
05.12.21

Future proof or reliable business model
Could be worthwhile Investment >10% per year
Higher risks for its business
Below average Marketposition
buy
Scryb Inc.

Start price
Target price
Perf. (%)
€0.42
01.04.21
€1.65
01.04.22
-68.78%
02.12.21

buy
Knight Therapeutics

Start price
Target price
Perf. (%)
€3.50
30.11.20
€4.00
30.11.21
5.14%
01.12.21

buy
Edesa Biotech Inc

Start price
Target price
Perf. (%)
€4.26
28.11.20
€5.50
28.11.21
40.85%
29.11.21

buy
Sirona Biochem Corp.

Start price
Target price
Perf. (%)
€0.22
19.01.21
€1.00
19.01.22
-37.99%
05.11.21

buy
Canada House Cannabis Group inc.

Start price
Target price
Perf. (%)
€0.60
02.10.20
€0.75
04.11.21
-20.00%
05.11.21

buy
Acasti Pharma Inc.

Start price
Target price
Perf. (%)
€9.79
22.09.20
€0.000
04.11.21
-5.64%
05.11.21

Edesa Biotech Inc

Start price
Target price
Perf. (%)
€6.15
21.09.20
€4.00
04.11.21
17.07%
05.11.21

Probably not worthwhile Investment
High valuation
buy
Emerald Health Therapeutics Inc

Start price
Target price
Perf. (%)
€0.14
24.07.20
€1.00
04.11.21
-56.86%
05.11.21

buy
AEterna Zentaris Inc.

Start price
Target price
Perf. (%)
€21.28
15.06.20
€30.00
04.11.21
-36.08%
05.11.21

buy
Avricore Health Inc.

Start price
Target price
Perf. (%)
€0.012
26.05.20
€0.010
04.11.21
743.48%
05.11.21